ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 057,80
-0,92%
Dow Jones
38 852,86
-0,55%
DAX
18 677,87
-0,45%
Brent Oil
84,215
-0,13%
Bitcoin
68 745,34
0,67%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Atreca Inc (BCEL)

  7. Atreca Inc (BCEL) Actualités

BCEL

Atreca (BCEL)

Atreca Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BCEL
DateHeureSourceTitreSymboleSociété
11/03/202421h12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
11/03/202421h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
05/01/202422h57Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:BCELAtreca Inc
26/12/202314h30GlobeNewswire Inc.Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to ImmunomeNASDAQ:BCELAtreca Inc
14/11/202322h30GlobeNewswire Inc.Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNASDAQ:BCELAtreca Inc
28/09/202301h20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
21/09/202314h00GlobeNewswire Inc.Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossNASDAQ:BCELAtreca Inc
18/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCELAtreca Inc
16/08/202323h20Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCELAtreca Inc
10/08/202322h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
10/08/202322h05GlobeNewswire Inc.Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringNASDAQ:BCELAtreca Inc
05/08/202300h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
19/07/202315h18Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCELAtreca Inc
16/06/202300h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
15/06/202322h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
05/06/202314h00GlobeNewswire Inc.Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
10/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCELAtreca Inc
10/05/202322h05GlobeNewswire Inc.Atreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsNASDAQ:BCELAtreca Inc
01/05/202317h00Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BCELAtreca Inc
27/04/202322h36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BCELAtreca Inc
27/04/202322h35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BCELAtreca Inc
26/04/202322h05GlobeNewswire Inc.Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
13/04/202314h00GlobeNewswire Inc.Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:BCELAtreca Inc
29/03/202323h24Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCELAtreca Inc
29/03/202322h05GlobeNewswire Inc.Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data UpdateNASDAQ:BCELAtreca Inc
29/03/202322h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCELAtreca Inc
23/03/202322h00GlobeNewswire Inc.Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023NASDAQ:BCELAtreca Inc
01/03/202314h00GlobeNewswire Inc.Atreca to Participate at Cowen’s 43rd Annual Health Care ConferenceNASDAQ:BCELAtreca Inc
06/02/202314h00GlobeNewswire Inc.Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor TargetNASDAQ:BCELAtreca Inc
12/01/202300h37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCELAtreca Inc
 Showing the most relevant articles for your search:NASDAQ:BCEL

Dernières Valeurs Consultées

UNSW3
ROCKSETH
ROCKI
BIT
I07916
Intesa Sanpaolo
BITMOT
889222
Intsanpaolo Sustainable ...
USOTC
EBJGF
Ebara Jitsugyo (PK)
KRKN
DYDXUSD
dYdX
EU
CLAMG
Climate Ambition 40 EW GR
NASDAQ
FBQKHX
Tactical Alpha Portfolio...
BOV
E1XC34R
Exelon
USOTC
GLAPY
Glanbia (PK)
USOTC
EVHEF
Event Hospitality & Ente... (PK)
ASX
MXRN
Maximus Resources
LSE
HMWD
Hsbc Msci Wrld$
USOTC
EBIXQ
Ebix (PK)
EU
I3PYP
LS 3PYP INAV
NASDAQ
FDT
First Trust Developed Ma...
KOSPI
012160
Youngwire
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés